Page last updated: 2024-12-08

stizolobic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

stizolobic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161158
CHEBI ID177665
MeSH IDM0060871

Synonyms (17)

Synonym
CHEBI:177665
4-[(2s)-2-amino-2-carboxyethyl]-6-oxopyran-2-carboxylic acid
C06047
15911-87-2
stizolobic acid
AC1L4OWY ,
2h-pyran-4-propanoic acid, alpha-amino-6-carboxy-2-oxo-, (s)-
qxp0p9096p ,
unii-qxp0p9096p
alpha-amino-6-carboxy-2-oxo-2h-pyran-4-propionic acid
l-stizolobic acid
2h-pyran-4-propanoic acid, .alpha.-amino-6-carboxy-2-oxo-, (.alpha.s)-
2h-pyran-4-propanoic acid, .alpha.-amino-6-carboxy-2-oxo-, (s)-
4-[(2s)-2-amino-2-carboxy-ethyl]-6-oxo-pyran-2-carboxylic acid
DTXSID90166588
Q7617709
(s)-4-(2-amino-2-carboxyethyl)-2-oxo-2h-pyran-6-carboxylic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
L-alpha-amino acidAny alpha-amino acid having L-configuration at the alpha-carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.51 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]